Secondary Prevention for Atherosclerotic Cardiovascular Disease-Panel Discussion: Variations in Practice

Video Transcription

Video Summary

In this video, Dr. Hogan, an interventional cardiologist, discusses the optimization of secondary prevention in patients with cardiovascular disease. She highlights the importance of advocating for patients and ensuring access to medications, even for uninsured or underinsured patients. Dr. Hogan emphasizes the importance of engaging patients and involving their family members in the care process. She also mentions the success of using PCSK9 inhibitors in her practice and the need to address patient concerns about side effects and medication costs. The panel also discusses the barriers in initiating statin therapy and the underutilization of combination therapy. They suggest involving pharmacists and educating primary care physicians to improve the utilization of these therapies. Overall, the panel emphasizes the need for comprehensive and aggressive approaches to secondary prevention, including the use of guideline-directed therapies and regular monitoring of lipid profiles.

Asset Subtitle

Drs. Doll, Hogan, Latif, Mukherjee, and Paul

Keywords

secondary prevention

medications access

patient engagement

PCSK9 inhibitors

combination therapy

lipid profiles monitoring